Tabula Rasa HealthCare Inc (TRHC) Shares Bought by Wasatch Advisors Inc.

Wasatch Advisors Inc. boosted its stake in shares of Tabula Rasa HealthCare Inc (NASDAQ:TRHC) by 31.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 199,448 shares of the company’s stock after purchasing an additional 48,111 shares during the period. Wasatch Advisors Inc.’s holdings in Tabula Rasa HealthCare were worth $5,595,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. New York State Common Retirement Fund grew its position in Tabula Rasa HealthCare by 257.0% during the 2nd quarter. New York State Common Retirement Fund now owns 10,000 shares of the company’s stock worth $151,000 after purchasing an additional 7,199 shares during the last quarter. Financial Consulate Inc. purchased a new stake in Tabula Rasa HealthCare during the 3rd quarter worth approximately $222,000. Teachers Advisors LLC grew its position in Tabula Rasa HealthCare by 203.5% during the 2nd quarter. Teachers Advisors LLC now owns 16,500 shares of the company’s stock worth $248,000 after purchasing an additional 11,063 shares during the last quarter. California State Teachers Retirement System grew its position in Tabula Rasa HealthCare by 60.2% during the 2nd quarter. California State Teachers Retirement System now owns 16,500 shares of the company’s stock worth $248,000 after purchasing an additional 6,200 shares during the last quarter. Finally, Rhumbline Advisers purchased a new stake in Tabula Rasa HealthCare during the 3rd quarter worth approximately $253,000. 31.85% of the stock is currently owned by institutional investors.

Shares of Tabula Rasa HealthCare Inc (TRHC) opened at $34.14 on Friday. The company has a market cap of $600.98, a price-to-earnings ratio of -136.56, a PEG ratio of 3.51 and a beta of 3.20. The company has a quick ratio of 0.66, a current ratio of 0.73 and a debt-to-equity ratio of 0.47. Tabula Rasa HealthCare Inc has a twelve month low of $11.59 and a twelve month high of $36.80.

Tabula Rasa HealthCare (NASDAQ:TRHC) last released its quarterly earnings data on Monday, November 6th. The company reported $0.08 EPS for the quarter, beating the consensus estimate of $0.06 by $0.02. The business had revenue of $33.27 million for the quarter, compared to the consensus estimate of $31.76 million. Tabula Rasa HealthCare had a negative net margin of 2.27% and a negative return on equity of 5.58%. The business’s revenue for the quarter was up 37.6% on a year-over-year basis. During the same period in the prior year, the firm earned $0.06 EPS. sell-side analysts predict that Tabula Rasa HealthCare Inc will post 0.03 earnings per share for the current fiscal year.

In other news, CFO Brian W. Adams bought 5,391 shares of the firm’s stock in a transaction that occurred on Friday, January 12th. The stock was purchased at an average cost of $14.23 per share, for a total transaction of $76,713.93. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Calvin H. Knowlton sold 8,000 shares of the business’s stock in a transaction on Monday, January 8th. The shares were sold at an average price of $32.75, for a total transaction of $262,000.00. The disclosure for this sale can be found here. Over the last quarter, insiders sold 1,099,180 shares of company stock valued at $28,483,763. Company insiders own 45.80% of the company’s stock.

Several analysts have weighed in on the stock. Zacks Investment Research raised shares of Tabula Rasa HealthCare from a “hold” rating to a “strong-buy” rating and set a $38.00 target price on the stock in a research report on Thursday, January 11th. BidaskClub raised shares of Tabula Rasa HealthCare from a “hold” rating to a “buy” rating in a report on Thursday, December 21st. Citigroup initiated coverage on shares of Tabula Rasa HealthCare in a report on Thursday, January 4th. They issued a “buy” rating on the stock. First Analysis initiated coverage on shares of Tabula Rasa HealthCare in a report on Wednesday, November 1st. They issued an “overweight” rating and a $41.00 price objective on the stock. Finally, William Blair initiated coverage on shares of Tabula Rasa HealthCare in a report on Monday, December 11th. They issued an “outperform” rating on the stock. Two equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $29.78.

TRADEMARK VIOLATION NOTICE: This story was first posted by Community Financial News and is the property of of Community Financial News. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright law. The legal version of this story can be accessed at https://www.com-unik.info/2018/01/19/tabula-rasa-healthcare-inc-trhc-shares-bought-by-wasatch-advisors-inc.html.

Tabula Rasa HealthCare Company Profile

Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.

Want to see what other hedge funds are holding TRHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tabula Rasa HealthCare Inc (NASDAQ:TRHC).

Institutional Ownership by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit